| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
1
Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology,
2
Biomedical Mass Spectrometry and Functional Proteomics Facility, Department of Biochemistry and Molecular Biology, and
3
Clinical Pharmacology Unit, Department of Pharmacology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
a Author for correspondence. Fax 507-266-2888; e-mail
o'brien.john{at}mayo.edu.
Background: Congenital disorders of glycosylation (CDG) are autosomal recessive disorders that produce increased serum carbohydrate-deficient transferrin (CDT) isoforms. Methods to resolve CDT from fully glycosylated transferrin (Trf) have been based on a neutral shift in the isoelectric focusing (IEF) pattern or on a reduction in the negative charge, allowing resolution by anion-exchange chromatography. Our purpose was to develop a method of resolution and relative quantification of Trf isoforms using online immunoaffinity liquid chromatography–mass spectrometry (LC-MS).
Methods: Serum (25 µL) was diluted with 100 µL of water before application to an immunoaffinity column that sequestered Trf isoforms. Trf isoforms were eluted from the immunoaffinity column, concentrated on a C4 column, eluted from the C4 column, and introduced into the mass spectrometer. Analysis of the Trf isoforms was entirely automated and completed in <10 min per sample.
Results: The LC-MS method demonstrated that the major abnormal Trf isoforms in CDG lack one complete oligosaccharide structure (mono-oligosaccharide) or both oligosaccharide structures (a-oligosaccharide), but not the sialic acids, as presumed on the basis of IEF methods. Calculation of relative ratios among three possible species (mono-/di-oligosaccharide and a-/di-oligosaccharide) is reproducible [mean intra- and interassay CVs were 9.3% (n = 10) and 10% (n = 5), respectively]. A reference range for patients <18 years was determined by analysis of 209 samples (for mono-/di-oligosaccharide, the median was 0.041 and the range was 0.018–0.083; for a-/di-oligosaccharide, the median was 0.007 and the range was 0.002–0.036). Comparison of data obtained with an affinity chromatography-IEF method and the LC-MS method demonstrated equivalence in the interpreted results (n = 170).
Conclusions: Advantages of the LC-MS method include improved sensitivity, minimal sample preparation, and an analysis time of <10 min. The method was automated, which allowed high throughput, with >100 samples analyzed in a single day. Moreover, the nature of the oligosaccharide defect in CDG is accurately reflected by mass resolution, and subtle oligosaccharide truncations may also be detected by this method.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. J. Hulsmeier, P. Paesold-Burda, and T. Hennet N-Glycosylation Site Occupancy in Serum Glycoproteins Using Multiple Reaction Monitoring Liquid Chromatography-Mass Spectrometry Mol. Cell. Proteomics, December 1, 2007; 6(12): 2132 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nedelkov, U. A. Kiernan, E. E. Niederkofler, K. A. Tubbs, and R. W. Nelson Population Proteomics: The Concept, Attributes, and Potential for Cancer Biomarker Research Mol. Cell. Proteomics, October 1, 2006; 5(10): 1811 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Ostrow, H. Freeze, and J. Rychik Protein-Losing Enteropathy After Fontan Operation: Investigations Into Possible Pathophysiologic Mechanisms Ann. Thorac. Surg., August 1, 2006; 82(2): 695 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Cohn, E. Eklund, A. L. Bergner, J. F. Casella, S. L. Woods, J. Althaus, K. J. Blakemore, H. E. Fox, J. E. Hoover-Fong, A. Hamosh, et al. Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation Pediatrics, August 1, 2006; 118(2): e514 - e521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sturiale, R. Barone, A. Fiumara, M. Perez, M. Zaffanello, G. Sorge, L. Pavone, S. Tortorelli, J. F. O'Brien, J. Jaeken, et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia Glycobiology, December 1, 2005; 15(12): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Helander, J. Bergstrom, and H. H. Freeze Testing for Congenital Disorders of Glycosylation by HPLC Measurement of Serum Transferrin Glycoforms Clin. Chem., May 1, 2004; 50(5): 954 - 958. [Full Text] [PDF]
|
|
|
|
|
|
B. Ramdani, V. Nuyens, T. Codden, G. Perpete, J. Colicis, A. Lenaerts, J.-P. Henry, and F. J. Legros Analyte Comigrating with Trisialotransferrin during Capillary Zone Electrophoresis of Sera from Patients with Cancer Clin. Chem., November 1, 2003; 49(11): 1854 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Magro, D. Perissinotto, M. Schiappacassi, S. Goletz, A. Otto, E.-C. Muller, M. Bisceglia, G. Brown, T. Ellis, S. Grasso, et al. Proteomic and Postproteomic Characterization of Keratan Sulfate-Glycanated Isoforms of Thyroglobulin and Transferrin Uniquely Elaborated by Papillary Thyroid Carcinomas Am. J. Pathol., July 1, 2003; 163(1): 183 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption Clin. Chem., March 1, 2003; 49(3): 440 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Whitfield Transferrin Isoform Analysis for the Diagnosis and Management of Hazardous or Dependent Drinking Clin. Chem., December 1, 2002; 48(12): 2095 - 2096. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Kroll, M. J. Magera, J. K. Helgeson, D. Matern, and P. Rinaldo Liquid Chromatographic-Tandem Mass Spectrometric Method for the Determination of 5-Hydroxyindole-3-acetic Acid in Urine Clin. Chem., November 1, 2002; 48(11): 2049 - 2051. [Full Text] [PDF]
|
|
|
|
|
|
H. H. Freeze Update and perspectives on congenital disorders of glycosylation Glycobiology, December 1, 2001; 11(12): 129R - 143R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Ford, M. J. Magera, K. M. Kloke, P. A. Chezick, A. Fauq, and J. P. McConnell Quantitative Measurement of Porphobilinogen in Urine by Stable-Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., September 1, 2001; 47(9): 1627 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Matern and M. J. Magera Mass Spectrometry Methods for Metabolic and Health Assessment J. Nutr., May 1, 2001; 131(5): 1615S - 1620. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
